Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism

[1]  E. Segal,et al.  Potential role of indolelactate and butyrate in multiple sclerosis revealed by integrated microbiome-metabolome analysis , 2021, Cell reports. Medicine.

[2]  E. Mowry,et al.  Vascular comorbidity is associated with lower brain volumes and lower neuroperformance in a large multiple sclerosis cohort , 2021, Multiple sclerosis.

[3]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[4]  D. Centonze,et al.  Re-Examining the Role of TNF in MS Pathogenesis and Therapy , 2020, Cells.

[5]  Oliver Fiehn,et al.  A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors , 2020, Cell.

[6]  H. Soininen,et al.  Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer’s Disease , 2020, Journal of Alzheimer's disease : JAD.

[7]  W. Swardfager,et al.  Untargeted metabolomic analysis of plasma from relapsing-remitting multiple sclerosis patients reveals changes in metabolites associated with structural changes in brain , 2019, Brain Research.

[8]  J. Giebułtowicz,et al.  Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson's disease. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[9]  Simon C. Potter,et al.  Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility , 2019, Science.

[10]  Jason W Locasale,et al.  Metabolic landscape of the tumor microenvironment at single cell resolution , 2019, Nature Communications.

[11]  V. Koval,et al.  Targeted metabolomics approach for identification of relapsing-remitting multiple sclerosis markers and evaluation of diagnostic models. , 2019, MedChemComm.

[12]  Kenichiro Sato,et al.  Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis , 2019, NeuroImage: Clinical.

[13]  L. Newby,et al.  Metabolome-based signature of disease pathology in MS. , 2019, Multiple sclerosis and related disorders.

[14]  Kyle A. Martin,et al.  Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation , 2019, bioRxiv.

[15]  Colin J. Brislawn,et al.  Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.

[16]  A. Heintz‐Buschart,et al.  Metabolites of lactic acid bacteria present in fermented foods are highly potent agonists of human hydroxycarboxylic acid receptor 3 , 2019, PLoS genetics.

[17]  Sagar,et al.  Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution , 2019, Nature.

[18]  Y. Shao,et al.  Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease , 2019, Molecular Neurodegeneration.

[19]  A. Butte,et al.  Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage , 2018, Nature Immunology.

[20]  P. Bhargava,et al.  Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes , 2018, Annals of clinical and translational neurology.

[21]  P. Bhargava,et al.  Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course , 2018, Annals of clinical and translational neurology.

[22]  N. Yosef,et al.  Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis , 2018, Nature Communications.

[23]  M. Mattson,et al.  Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis. , 2018, Multiple sclerosis and related disorders.

[24]  E. Waubant,et al.  Dietary factors and pediatric multiple sclerosis: A case-control study , 2018, Multiple sclerosis.

[25]  Laleh Haghverdi,et al.  Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors , 2018, Nature Biotechnology.

[26]  C. Wolfson,et al.  Effects of physical comorbidities on disability progression in multiple sclerosis , 2018, Neurology.

[27]  L. Atzori,et al.  Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis. , 2017, The international journal of biochemistry & cell biology.

[28]  G. Nolan,et al.  A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites , 2017, Nature.

[29]  K. Takeda,et al.  Slc3a2 Mediates Branched-Chain Amino-Acid-Dependent Maintenance of Regulatory T Cells. , 2017, Cell reports.

[30]  Keiichiro Suzuki,et al.  Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior , 2017, Nature Immunology.

[31]  Markus Krummenacker,et al.  The MetaCyc database of metabolic pathways and enzymes , 2017, Nucleic acids research.

[32]  E. Waubant,et al.  Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[33]  P. Bhargava,et al.  Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation. , 2017, JCI insight.

[34]  Roberto Montemanni,et al.  PCSF: An R-package for network-based interpretation of high-throughput data , 2017, PLoS Comput. Biol..

[35]  Chih‐Chung Lin,et al.  New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis , 2017, The Journal of Immunology.

[36]  Russell T. Shinohara,et al.  Harmonization of cortical thickness measurements across scanners and sites , 2017, NeuroImage.

[37]  J. Aerts,et al.  SCENIC: Single-cell regulatory network inference and clustering , 2017, Nature Methods.

[38]  Bruce V. Taylor,et al.  Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression , 2017, Scientific Reports.

[39]  X. Montalban,et al.  Metabolomic signatures associated with disease severity in multiple sclerosis , 2017, Neurology: Neuroimmunology & Neuroinflammation.

[40]  C. Newgard,et al.  Metabolomics and Metabolic Diseases: Where Do We Stand? , 2017, Cell metabolism.

[41]  Davis J. McCarthy,et al.  A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor , 2016, F1000Research.

[42]  Aaron T. L. Lun,et al.  Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R , 2017, Bioinform..

[43]  C. Crainiceanu,et al.  Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls , 2016, Multiple sclerosis.

[44]  N. Pochet,et al.  Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and CNS inflammation via the aryl hydrocarbon receptor , 2016, Nature Medicine.

[45]  A. Ascherio,et al.  Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention—An Update , 2016, Seminars in Neurology.

[46]  P. Sly,et al.  Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. , 2015, American journal of respiratory cell and molecular biology.

[47]  Snehashis Roy,et al.  Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four‐year study , 2015, Annals of neurology.

[48]  Jerry L Prince,et al.  Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials , 2015, Multiple sclerosis international.

[49]  Jeffrey A. Cohen,et al.  The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review , 2015, Multiple sclerosis.

[50]  M. Turner,et al.  A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis , 2014, Neurology.

[51]  Jerry L Prince,et al.  Retinal layer segmentation of macular OCT images using boundary classification , 2013, Biomedical optics express.

[52]  A. Ghezzi,et al.  International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions , 2013, Multiple sclerosis.

[53]  Chester Ni,et al.  In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6–Mediated Signaling , 2013, Science Translational Medicine.

[54]  Shiv Saidha,et al.  Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. , 2012, JAMA neurology.

[55]  G. Siuzdak,et al.  Innovation: Metabolomics: the apogee of the omics trilogy , 2012, Nature Reviews Molecular Cell Biology.

[56]  Peter Langfelder,et al.  Fast R Functions for Robust Correlations and Hierarchical Clustering. , 2012, Journal of statistical software.

[57]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .

[58]  Davis J. McCarthy,et al.  Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation , 2012, Nucleic acids research.

[59]  M. Onofrj,et al.  Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis. , 2011, Journal of proteomics.

[60]  Hadley Wickham,et al.  Dates and Times Made Easy with lubridate , 2011 .

[61]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[62]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[63]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[64]  Søren Højsgaard,et al.  The R Package geepack for Generalized Estimating Equations , 2005 .

[65]  Christian von Mering,et al.  STRING: known and predicted protein–protein associations, integrated and transferred across organisms , 2004, Nucleic Acids Res..

[66]  Jason Fine,et al.  Estimating equations for association structures , 2004, Statistics in medicine.

[67]  E. Paley.  Discovery of Gut Bacteria Specific to Alzheimer's Associated Diseases is a Clue to Understanding Disease Etiology: Meta-Analysis of Population-Based Data on Human Gut Metagenomics and Metabolomics. , 2019, Journal of Alzheimer's disease : JAD.

[68]  D. Reich,et al.  Multiple Sclerosis , 2018, The New England journal of medicine.